Expression of thymidine phosphorylase and vascular endothelial cell growth factor in human head and neck squamous cell carcinoma and their different characteristics
- PMID: 10091776
- DOI: 10.1002/(sici)1097-0142(19990215)85:4<960::aid-cncr26>3.0.co;2-p
Expression of thymidine phosphorylase and vascular endothelial cell growth factor in human head and neck squamous cell carcinoma and their different characteristics
Abstract
Background: Thymidine phosphorylase (dThdPase) is identical to platelet-derived endothelial cell growth factor (PD-ECGF). dThdPase is known to promote the development of new blood vessels, which are fundamental to tumor growth and metastasis. Vascular endothelial growth factor (VEGF) is a 34-42 kilodalton (kD) protein that induces both angiogenesis and vascular permeability. Proliferating cell nuclear antigen (PCNA) is a 36 kD nuclear protein, and its expression is associated with DNA synthesis and cell proliferation.
Methods: The authors investigated the correlations of dThdPase and VEGF with the growth of head and neck squamous cell carcinoma (HNSCC) in 95 patients by examining PCNA expression as a marker of tumor proliferation. They also retrospectively examined the expression of dThdPase in primary HNSCC and its association with angiogenesis and clinicopathologic findings.
Results: Microvessel count was significantly correlated with the expression of VEGF (P = 0.046) but not with dThdPase expression. The expression of PCNA was significantly correlated with dThdPase (P < 0.001) but not VEGF expression. A significant correlation was found between VEGF and dThdPase expression (P = 0.003). Neither dThdPase nor VEGF correlated with clinicopathologic findings, except for the correlation between tumor location and VEGF expression (P 0.020).
Conclusions: These findings suggest that VEGF is involved in angiogenesis in HNSCC. dThdPase may have effects on tumor growth other than angiogenic activity in HNSCC.
Similar articles
-
Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in human colorectal cancer.Cancer Lett. 1997 Nov 11;119(2):227-35. doi: 10.1016/s0304-3835(97)00280-2. Cancer Lett. 1997. PMID: 9570376
-
Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis.Eur J Cancer. 1998 Aug;34(9):1439-47. doi: 10.1016/s0959-8049(98)00069-0. Eur J Cancer. 1998. PMID: 9849429
-
Prognostic significance of expression of thymidine phosphorylase and vascular endothelial growth factor in human gastric carcinoma.J Surg Oncol. 2001 Jan;76(1):31-6. doi: 10.1002/1096-9098(200101)76:1<31::aid-jso1006>3.0.co;2-9. J Surg Oncol. 2001. PMID: 11223822
-
Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy.Br J Cancer. 1997;76(6):689-93. doi: 10.1038/bjc.1997.447. Br J Cancer. 1997. PMID: 9310231 Free PMC article. Review.
-
Clinical significance of the determination of angiogenic factors.Eur J Cancer. 1996 Dec;32A(14):2513-9. doi: 10.1016/s0959-8049(96)00397-8. Eur J Cancer. 1996. PMID: 9059341 Review. No abstract available.
Cited by
-
Co-expression of thymidine phosphorylase and heme oxygenase-1 in macrophages in human malignant vertical growth melanomas.Jpn J Cancer Res. 2000 Sep;91(9):906-10. doi: 10.1111/j.1349-7006.2000.tb01033.x. Jpn J Cancer Res. 2000. PMID: 11011118 Free PMC article.
-
Tumor specific activation of the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell head and neck carcinomas.Clin Exp Metastasis. 2000;18(4):313-9. doi: 10.1023/a:1011083121295. Clin Exp Metastasis. 2000. PMID: 11448062
-
The dual role of thymidine phosphorylase in cancer development and chemotherapy.Med Res Rev. 2009 Nov;29(6):903-53. doi: 10.1002/med.20159. Med Res Rev. 2009. PMID: 19434693 Free PMC article. Review.
-
Prognostic value of activated Akt expression in oral squamous cell carcinoma.J Clin Pathol. 2005 Nov;58(11):1199-205. doi: 10.1136/jcp.2004.024786. J Clin Pathol. 2005. PMID: 16254112 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous